XML 75 R41.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Collaborative and Other Relationships Collaborative and Other Relationships (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Cash reimbursement as an adjustment to the Base Rate | We expect to recognize the effect of the cash reimbursement as an adjustment to the Base Rate in the table below over a ten year period, consistent with the initial patent term of the products. Under the collaboration agreement, cash payments are as follows:
|  |  | Rates post Sobi Opt-In(3)
Royalty and Net Revenue Share Rates: | Method |  | Base Rate following 1st commercial sale in the Sobi Territory: |  | Rate during the Reimbursement Period:
Sobi rate to Biogen on net sales in the Sobi Territory | Royalty |  | 12% |  | Base Rate plus 5%
Biogen rate to Sobi on net sales in the Biogen North America Territory | Royalty |  | 12% |  | Base Rate less 5%
Biogen rate to Sobi on net sales in the Biogen Direct Territory | Royalty |  | 17% |  | Base Rate less 5%
Biogen rate to Sobi on net revenue(1) from the Biogen Distributor Territory(2) | Net Revenue Share |  | 50% |  | Base Rate less 15%

X
- Definition Mechanism for reimbursement, under the amended agreement amounts payable. + References No definition available. + Details
Name: | biib_ReimbursementUnderAmendedAgreementAmountsPayableTableTextBlock
Namespace Prefix: | biib_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration